搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
Premium Times
11 小时
N5.3bn Refund: NAHCON urges EFCC, ICPC to monitor payment to 2023 pilgrims
NAHCON said the monitoring of the refund process by the anti-graft agencies would guarantee transparency and accountability.
3 天
A peek into the life and culture of the pastoral Kurubas of Karnataka
For seven decades, he walked his sheep through this landscape until his son, Nagesh, died in an accident, and he had to give ...
clinicaltrialsarena
4 天
Amgen share price plummets despite Phase II weight loss success
Amgen reported 20% weight loss in its MariTide Phase II study results, but a 10% drop in share price suggests investors had ...
vitalthrills
4 天
Asia Natural History Series Coming to AMC+ and BBC America
AMC Networks has announced that the natural history series Asia will premiere on Saturday, January 25 at 8 p.m. ET/PT on BBC ...
businessday
4 天
Plateau proposes ₦471.13bn budget for 2025, focuses on growth, infrastructure
Plateau State Government has proposed a total budget estimate of ₦471.13 billion for the 2025 fiscal year, reflecting a ...
Stocktwits on MSN
4 天
Amgen Stock Sinks On Modest Obesity Drug Results, But Retail Sentiment Remains Steady
Amgen, Inc. ($AMGN) shares nosedived in Tuesday’s pre-market session after the biopharma announced Phase-2 data for its ...
4 天
5 things to know before the stock market opens Tuesday
Trump is preparing his tariff policy. The President-elect said Monday he'd impose additional tariffs of 10% on all goods from ...
4 天
Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau
The results shed light on how MariTide may measure up to weight loss injections from Novo Nordisk and Eli Lilly and other ...
4 天
AMGEN ANNOUNCES ROBUST WEIGHT LOSS WITH MARITIDE IN PEOPLE LIVING WITH OBESITY OR ...
Amgen (NASDAQ:AMGN) today announced positive data at 52 weeks in a double-blind, dose-ranging Phase 2 study with MariTide ...
4 天
Amgen posts mid-stage data for weight loss therapy
Amgen (AMGN) stock slips as company posts mid-stage trial data for weight loss therapy MariTide. Rivals Eli Lilly (LLY) and ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈